306 related articles for article (PubMed ID: 7706735)
1. T lymphocytes infiltrating sites of tumor rejection and progression display identical V beta usage but different cytotoxic activities.
Kurt RA; Park JA; Panelli MC; Schluter SF; Marchalonis JJ; Carolus B; Akporiaye ET
J Immunol; 1995 Apr; 154(8):3969-74. PubMed ID: 7706735
[TBL] [Abstract][Full Text] [Related]
2. Limited T cell antigen receptor repertoire in tumor-infiltrating lymphocyte and inhibition of experimental lung metastasis of murine melanoma by anti-TCR antibody.
Wang R; Taniguchi M
J Immunol; 1995 Feb; 154(4):1797-803. PubMed ID: 7836764
[TBL] [Abstract][Full Text] [Related]
3. T-cell subset analysis of Lewis lung carcinoma tumor rejection: heterogeneity of effectors and evidence for negative regulatory lymphocytes correlating with metastasis.
Gelber C; Eisenbach L; Feldman M; Goodenow RS
Cancer Res; 1992 Dec; 52(23):6507-15. PubMed ID: 1423297
[TBL] [Abstract][Full Text] [Related]
4. Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions.
Lundqvist C; Melgar S; Yeung MM; Hammarström S; Hammarström ML
J Immunol; 1996 Sep; 157(5):1926-34. PubMed ID: 8757311
[TBL] [Abstract][Full Text] [Related]
5. Isolation and reactivity of host effectors associated with the manifestation of concomitant tumor immunity.
Akporiaye ET; Kudalore M; Stevenson AP; Kraemer PM; Stewart CC
Cancer Res; 1988 Mar; 48(5):1153-8. PubMed ID: 3257713
[TBL] [Abstract][Full Text] [Related]
6. Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells.
Seo N; Tokura Y; Takigawa M; Egawa K
J Immunol; 1999 Jul; 163(1):242-9. PubMed ID: 10384122
[TBL] [Abstract][Full Text] [Related]
7. Different tumours, transduced with different cytokine genes as G-CSF and IL-2, show inhibition of tumour take through neutrophil activation but differ in T cell functions.
Stoppacciaro A; Forni G; Colombo MP
Folia Biol (Praha); 1994; 40(1-2):89-99. PubMed ID: 7525363
[TBL] [Abstract][Full Text] [Related]
8. Studies on the minimum requirements for in vitro "cure" of tumor cells by cytotoxic T lymphocytes.
Miki S; Ksander B; Streilein JW
Reg Immunol; 1992; 4(6):352-62. PubMed ID: 1297406
[TBL] [Abstract][Full Text] [Related]
9. The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.
Weidmann E; Whiteside TL; Giorda R; Herberman RB; Trucco M
Cancer Res; 1992 Nov; 52(21):5913-20. PubMed ID: 1382847
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression.
Fischer AC; Ruvolo PP; Burt R; Horwitz LR; Bright EC; Hess JM; Beschorner WE; Hess AD
J Immunol; 1995 Apr; 154(8):3713-25. PubMed ID: 7706714
[TBL] [Abstract][Full Text] [Related]
11. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha.
Musiani P; Allione A; Modica A; Lollini PL; Giovarelli M; Cavallo F; Belardelli F; Forni G; Modesti A
Lab Invest; 1996 Jan; 74(1):146-57. PubMed ID: 8569177
[TBL] [Abstract][Full Text] [Related]
12. Involvement of TCR-V beta 8.3+ cells in the cure of mice bearing a large MOPC-315 tumor by low dose melphalan.
Mokyr MB; Rubin M; Newell KA; Prokhorova A; Bluestone JA
J Immunol; 1993 Nov; 151(9):4838-46. PubMed ID: 8409442
[TBL] [Abstract][Full Text] [Related]
13. Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinomas.
Ikeda H; Sato N; Matsuura A; Kikuchi K
Cancer Res; 1993 Jul; 53(13):3078-84. PubMed ID: 8391386
[TBL] [Abstract][Full Text] [Related]
14. In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma.
Gaudin C; Dietrich PY; Robache S; Guillard M; Escudier B; Lacombe MJ; Kumar A; Triebel F; Caignard A
Cancer Res; 1995 Feb; 55(3):685-90. PubMed ID: 7834641
[TBL] [Abstract][Full Text] [Related]
15. T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer.
Peoples GE; Davey MP; Goedegebuure PS; Schoof DD; Eberlein TJ
J Immunol; 1993 Nov; 151(10):5472-80. PubMed ID: 8228239
[TBL] [Abstract][Full Text] [Related]
16. Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma.
Zeuthen J; Birck A; Straten PT
Arch Immunol Ther Exp (Warsz); 1995; 43(2):123-33. PubMed ID: 8744727
[TBL] [Abstract][Full Text] [Related]
17. Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma.
Choudhary A; Davodeau F; Moreau A; Peyrat MA; Bonneville M; Jotereau F
J Immunol; 1995 Apr; 154(8):3932-40. PubMed ID: 7706731
[TBL] [Abstract][Full Text] [Related]
18. Structure and repertoire usage of rat TCR alpha-chain genes in T cells infiltrating heart allografts.
Shirwan H; Barwari L; Fuss I; Makowka L; Cramer DV
J Immunol; 1995 Feb; 154(4):1964-72. PubMed ID: 7836776
[TBL] [Abstract][Full Text] [Related]
19. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
Alleva DG; Burger CJ; Elgert KD
J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
[TBL] [Abstract][Full Text] [Related]
20. Insight into the mechanism of TCR-V beta 8+/CD8+ T cell-mediated MOPC-315 tumor eradication.
Mokyr MB; Prokhorova A; Rubin M; Bluestone JA
J Immunol; 1994 Oct; 153(7):3123-34. PubMed ID: 8089490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
